Advertisement

Current Concepts in Diagnosis and Staging of Lung Cancer

  • J. J. Erasmus
  • A. N. Leung

Abstract

Thoracic imaging has an important role in the evaluation of patients with lung cancer: it is used in the detection, diagnosis, and staging of the disease as well as in assessing the response to therapy and monitoring for tumor recurrence after treatment. This article reviews the diagnosis and staging of non-small-cell lung cancer (NSCLC), emphasizing the appropriate use of computer tomography (CT), magnetic resonance (MR), and positron emission tomography (PET) imaging in patient management.

Keywords

Lung Cancer Positron Emission Tomography Computer Tomography Positron Emission Tomography Imaging Pulmonary Nodule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Martini N, Melamed MR (1975) J Thorac Cardiovas Surg 70:606–612Google Scholar
  2. 2.
    Antoch G, Stattaus J, Nemat AT et al (2003) Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229:526–533PubMedCrossRefGoogle Scholar
  3. 3.
    Gould MK, Sanders GD, Barnett PG et al (2003) Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med 138:724–735PubMedGoogle Scholar
  4. 4.
    Viggiano RW, Swensen SJ, Rosenow EC 3rd (1992) Evaluation and management of solitary and multiple pulmonary nodules. Clin Chest Med 13:83–95PubMedGoogle Scholar
  5. 5.
    Matsuoka S, Kurihara Y, Yagihashi K et al (2005) Peripheral solitary pulmonary nodule: CT findings in patients with pulmonary emphysema. Radiology 234:266–273CrossRefGoogle Scholar
  6. 6.
    Kui M, Templeton PA, White CS et al (1996) Evaluation of the air bronchogram sign on CT in solitary pulmonary lesions. J Comput Assist Tomogr 20:983–986PubMedCrossRefGoogle Scholar
  7. 7.
    Henschke CI, Yankelevitz DF, Mirtcheva R et al (2002) CT screening for lung cancer: frequency and significance of partsolid and nonsolid nodules. AJR Am J Roentgenol 178:1053–1057PubMedGoogle Scholar
  8. 8.
    Zwirewich CV, Vedal S, Miller RR et al (1991) Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology 179:469–476PubMedGoogle Scholar
  9. 9.
    Swensen SJ, Silverstein MD, Ilstrup DM et al (1997) The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med 157:849–855PubMedCrossRefGoogle Scholar
  10. 10.
    Gould MK, Maclean CC, Kuschner WG et al (2001) Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285:914–924PubMedCrossRefGoogle Scholar
  11. 11.
    Gould MK, Sanders GD, Barnett PG et al (2003) Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med 138:724–735PubMedGoogle Scholar
  12. 12.
    MacMahon H, Austin JH, Gamsu G et al (2005) Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 237:395–400PubMedCrossRefGoogle Scholar
  13. 13.
    Lardinois D, Weder W, Hany TF et al (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507PubMedCrossRefGoogle Scholar
  14. 14.
    Reed CE, Harpole DH, Posther KE et al (2003) Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 126:1943–1951PubMedCrossRefGoogle Scholar
  15. 15.
    van Tinteren H, Hoekstra OS, Smit EF et al (2002) Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359:1388–1393PubMedCrossRefGoogle Scholar
  16. 16.
    Burnett RJ, Wood DE (1999) The new lung cancer staging system: what does it mean? Surg Oncol Clin North Am 8:231–244Google Scholar
  17. 17.
    Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710–1717PubMedGoogle Scholar
  18. 18.
    Leong SS, Lima CMR, Sherman CA, Green MR (1999) The 1997 international staging system for non-small cell lung cancer. Chest 115:242–248PubMedCrossRefGoogle Scholar
  19. 19.
    Mountain CF, Dresler CM (1997) Regional lymph node classification for lung cancer staging. Chest 111:1718–1723PubMedGoogle Scholar
  20. 20.
    Naruke T, Suemasu K, Ishikawa S (1978) Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 76:832–839PubMedGoogle Scholar
  21. 21.
    McLoud TC, Bourgouin PM, Greenberg RW et al (1992) Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 182:319–323PubMedGoogle Scholar
  22. 22.
    Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL (1999) Metastases from non-small cell lung cancer: mediastinal staging in the 1990’s-meta-analytic comparison of PET and CT. Radiology 213:530–536PubMedGoogle Scholar
  23. 23.
    Vansteenkiste JF, Stroobants SG, De Leyn PR et al (1998) Lymph node staging in non-small-cell lung cancer with FDGPET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16:2142–2149PubMedGoogle Scholar
  24. 24.
    Antoch G, Stattaus J, Nemat AT et al (2003) Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229:526–533PubMedCrossRefGoogle Scholar
  25. 25.
    Quint LE, Francis IR (1999) Radiologic staging of lung cancer. J Thorac Imaging 1999 14:235–246PubMedCrossRefGoogle Scholar
  26. 26.
    Boland GW, Lee MJ, Gazelle GS et al (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171:201–204PubMedGoogle Scholar
  27. 27.
    Mayo-Smith WW, Boland GW, Noto RB, Lee MJ (2001) State-of-the-art adrenal imaging. Radiographics 21:995–1012PubMedGoogle Scholar
  28. 28.
    Silvestri GA, Littenberg B, Colice GL (1995) The clinical evaluation for detecting metastatic lung cancer. A meta-analysis. Am J Respir Crit Care Med 152:225–230PubMedGoogle Scholar
  29. 29.
    MacManus MP, Hicks RJ, Matthews JP et al (2001) High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy. Int J Radiat Oncol Biol Phys 50:287–293PubMedCrossRefGoogle Scholar
  30. 30.
    Viney RC, Boyer MJ, King MT et al (2004) Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer. J Clin Oncol 22:2357–2362PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • J. J. Erasmus
    • 1
  • A. N. Leung
    • 2
  1. 1.Division of Diagnostic ImagingThe University of Texas, M. D. Anderson Cancer CenterHoustonUSA
  2. 2.Department of RadiologyStanford University Medical CenterStanfordUSA

Personalised recommendations